SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2024 • Ventyx Biosciences, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 23, 2024, by and between Ventyx Biosciences, Inc., a Delaware corporation (the “Company”), and Aventis Inc., a company organized and existing under the laws of Pennsylvania, having registered offices at 55 Corporate Drive, Bridgewater, New Jersey 08807 (the “Purchaser”).
